Results 31 to 40 of about 28,266 (219)
, 2016 The term “thrombophilia” is generally used to designate states of hypercoagulability caused by an inherent abnormality of the coagulation system, resulting in an increased risk of thrombosis.
Simon Mantha +3 more
core +1 more source
Trombofilija je sklonost za nastanak tromboze te uključuje nasljedne ili stečene poremećaje s povećanom tendencijom za nastanak tromboze. Iako su vrlo brojna stečena stanja i bolesti koji se ubrajaju u stečenu trombofiliju, tradicionalno se pojam ...
Nežić, Petra, Pulanić, Dražen
core +2 more sources
A call to action: MTHFR polymorphisms should not be a part of inherited thrombophilia testing
Research and Practice in Thrombosis and Haemostasis, 2022 Testing for polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene is still a standard part of thrombophilia testing in many laboratories. However, it is clear that these polymorphisms are not risk factors for arterial or venous thrombosis
Thomas G. Deloughery +4 more
doaj +1 more source
Structural Control of Stromal‐Immune Coupling by COL24A1 Underlies Pregnancy Maintenance
Advanced Science, EarlyView.COL24A1 emerges as a collagen‐associated regulator of maternal‐fetal interface homeostasis. Its deficiency promotes a maladaptive TIMP1‐high stromal state, impaired ECM turnover, collagen accumulation, and stromal–immune dysregulation, contributing to pregnancy loss.
Teng Wu +12 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1447-1454, April 2025.This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo +10 more
wiley +1 more source
Whole-exome sequencing in evaluation of patients with venous thromboembolism
Blood Advances, 2017 : Genetics play a significant role in venous thromboembolism (VTE), yet current clinical laboratory-based testing identifies a known heritable thrombophilia (factor V Leiden, prothrombin gene mutation G20210A, or a deficiency of protein C, protein S, or ...
Eun-Ju Lee +25 more
doaj +1 more source
Gout in pregnancy: Obstetric and neonatal outcomes
International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 349-355, April 2025.Abstract Objective The pregnancy, delivery, and neonatal outcomes of pregnancies complicated by gout have yet to be evaluated in a population‐based study. We sought to evaluate the obstetric and neonatal outcomes in pregnant patients with gout using a national population database.
Sam Amar +3 more
wiley +1 more source
Diagnostic implications and effective treatment of Susac syndrome with thrombophilia
, 2016 Susac syndrome is an uncommon autoimmune microangiopathy characterized by a combination of encephalopathy, branch retinal artery occlusions (BRAO), and hearing loss.
Ewa Czaplicka +2 more
core +1 more source
Blood Advances, 2017 : Routine testing for inherited and acquired thrombophilia defects is frequently performed in pediatric patients with thromboembolic events (TEEs). No consensus guidelines exist regarding the timing of testing or the type of patients to be tested.
Chakri Gavva +2 more
doaj +1 more source
Fetal growth trajectories and neonatal outcomes: A French population‐based study
International Journal of Gynecology &Obstetrics, EarlyView.Abstract Objective This study assesses whether fetal growth trajectories are associated with neonatal outcomes. Methods The study population included 8537 singleton liveborn infants from the 2021 French National Perinatal Survey. Fetal growth trajectories were assessed between second and third trimester routine ultrasounds and between the third ...
Pierre Gibert +22 more
wiley +1 more source